
|Videos|October 11, 2016
Measuring Outcomes in Atopic Dermatitis
Advertisement
Panelists Peter L. Salgo, MD; Jonathan Silverberg, MD, PhD, MPH; Cheryl Allen, BS Pharm, MBA; and Jeffrey D. Dunn, PharmD, MBA, discuss the safety and selection of long-term treatments in atopic dermatitis.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer
2
SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer
3
Pharmacist Spotlight: Kelly Gable, PharmD, BCPP, FAAPP
4
Ribociclib Plus Fulvestrant Shows Strong PFS and OS Benefits in Patients With Invasive Lobular Carcinoma
5

















































































































































































































